Literature DB >> 27629757

Prospective Comparison of Magnetic Resonance Imaging, Transrectal and Transperineal Sonography, and Surgical Findings in Complicated Perianal Crohn Disease.

Renáta Bor1, Klaudia Farkas1, Anita Bálint1, Mónika Szűcs2, Szabolcs Ábrahám3, Ágnes Milassin1, Mariann Rutka1, Ferenc Nagy1, Péter Milassin4, Zoltán Szepes1, Tamás Molnár5.   

Abstract

OBJECTIVES: Magnetic resonance imaging (MRI) and transrectal sonography are the two accepted imaging modalities for evaluation of perianal fistulas and abscesses. Transperineal sonography is a new technique that is easy to learn and can be performed at any time. The purpose of this study was to prospectively compare the diagnostic accuracy of MRI, transrectal sonography, and transperineal sonography with surgical findings in patients with perianal Crohn disease.
METHODS: All patients with perianal Crohn disease underwent MRI, transrectal sonography, and transperineal sonography within a few days before surgery. Fistulas were classified as simple (43.8%) or complex (52.2%) based on surgical findings.
RESULTS: Twenty-three patients with active perianal Crohn disease (12 women and 11 men; mean age, 29.9 years; current therapy: antibiotics, 69.6%; azathioprine, 56.5%; and biologics, 73.9%; previous surgery, 26.1%; and proportion of smokers, 39.1%) were included. Sensitivity values for MRI, transrectal sonography, and transperineal sonography for diagnosis of fistulas were 84.6%, 84.6%, and 100%, respectively. Transperineal sonography was more sensitive for diagnosis of perianal abscesses than MRI and transrectal sonography (100%, 58.8%, and 92.8%).
CONCLUSIONS: Transperineal sonography is a very accurate diagnostic method with outstanding sensitivity compared with MRI and transrectal sonography for evaluation of complicated perianal Crohn disease. Due to its simplicity and low cost, it is recommended that transperineal sonography be the first diagnostic modality in these cases.
© 2016 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  gastrointestinal ultrasound; perianal Crohn disease; perianal fistula; transperineal sonography; transrectal sonography

Mesh:

Year:  2016        PMID: 27629757     DOI: 10.7863/ultra.15.09043

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

1.  Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis.

Authors:  Alexander T Hawkins; Jun W Um; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2017-12-13

Review 2.  Role of magnetic resonance imaging in the management of perianal Crohn's disease.

Authors:  Jose C Gallego; Ana Echarri
Journal:  Insights Imaging       Date:  2017-11-15

3.  Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Authors:  Jianjian Xiang; Huaqing Yan; Jiangfeng Li; Xiao Wang; Hong Chen; Xiangyi Zheng
Journal:  World J Surg Oncol       Date:  2019-02-13       Impact factor: 2.754

Review 4.  EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3: Endorectal, Endoanal and Perineal Ultrasound.

Authors:  Dieter Nuernberg; Adrian Saftoiu; Ana Paula Barreiros; Eike Burmester; Elena Tatiana Ivan; Dirk-André Clevert; Christoph F Dietrich; Odd Helge Gilja; Torben Lorentzen; Giovanni Maconi; Ismail Mihmanli; Christian Pallson Nolsoe; Frank Pfeffer; Søren Rafael Rafaelsen; Zeno Sparchez; Peter Vilmann; Jo Erling Riise Waage
Journal:  Ultrasound Int Open       Date:  2019-02-05

5.  Transperineal ultrasonography for treatment response evaluation in children with perianal Crohn's disease.

Authors:  Jae Hyeop Jung; Young Jin Ryu; Ji Young Kim; Hye Ran Yang
Journal:  Ultrasonography       Date:  2022-07-03

Review 6.  Approach to medical therapy in perianal Crohn's disease.

Authors:  Abhinav Vasudevan; David H Bruining; Edward V Loftus; William Faubion; Eric C Ehman; Laura Raffals
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.